Press "Enter" to skip to content

Analysis of Europe Veterinary Vaccine Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

Europe

The “Europe Veterinary Vaccine Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Europe Veterinary Vaccine industry. The information available in the Europe Veterinary Vaccine market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Europe Veterinary Vaccine market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Europe Veterinary Vaccine Market:

  • Merck & Co. Inc.
  • Virbac SA
  • Hester Biosciences Ltd
  • Eli Lilly & Company
  • Ceva Sante Animale
  • Phibro Animal Health Corp.
  • HIPRA
  • Zoetis Inc.
  • Boehringer Ingelheim International GmbH

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245083

    Market Overview:

  • The European veterinary vaccine market is expected to witness a CAGR of 5.57% over the forecast period, 2019-2024. The key factors propelling the growth of this market are increasing incidences of livestock diseases, initiatives by various government agencies, animal associations, leading players in the European region, and the increasing incidences of zoonotic diseases.
  • In 2018, Boehringer Ingelheim announced its plans to invest EUR 65 million in France for the production of avian vaccines, as its demand increased with an increase in poultry consumption. Moreover, the Veterinary Vaccinology Network (VVN) is an association of the United Kingdom, which takes care of veterinary vaccines in the country. The VVN association is working to introduce new developments, along with the latest tools, and technologies to meet the needs of veterinary vaccinology in the country. Furthermore, in 2017, Spain implemented the Brucellosis Eradication Program with a target of reducing the number of cases of brucellosis at the end of 2018 and complete eradication by 2019.
  • The aforementioned statements indicate that veterinary health is an essential part for the European countries and good care of animal health is taken, which is a prime factor that augments the growth of the European veterinary vaccine market.

    Scope of the Report:

  • The European veterinary vaccine market has been segmented based on vaccine type, technology, and geography. By vaccine type, the market is divided into livestock vaccines and companion animal vaccines. By technology, the market is divided into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other technologies.

    Reasons for Buying Europe Veterinary Vaccine Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245083

    Key Market Trends:

    Live Attenuated Vaccines Segment is Expected to hold the Largest Market Share

    The live attenuated vaccines segment of the European veterinary vaccine market is believed to have the largest market size, and it is expected to witness a CAGR of approximately 5.12% over the forecast period.

    All vaccines licensed for oral or intranasal administration are attenuated. These vaccines must be stored and handled properly, with strict attention to temperature, even in the lyophilized (free-dried) state. After the reconstitution, the dose of the vaccine should be administered promptly (within 1 hour) or discarded. Some examples of these type of vaccines include canine distemper virus vaccines and all canine parvovirus and adenovirus-2 vaccines.

    Owing to the rising use of live attenuated vaccines, the segment is contributing to the largest market share of the European veterinary vaccine market.

    Europe Veterinary Vaccine Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 3850 USD for single user license) – https://www.industryresearch.co/purchase/14245083

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Europe Veterinary Vaccine Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Incidences of Livestock Diseases
    4.2.2 Initiatives by Various Government Agencies, Animal Associations, and Leading Players
    4.2.3 Increasing Incidences of Zoonotic Diseases
    4.3 Market Restraints
    4.3.1 High Storage Costs for Vaccines
    4.3.2 Lack of Veterinarians and Shortage of Skilled Farms
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Animal Vaccine Type
    5.1.1 Livestock Vaccines
    5.1.1.1 Bovine Vaccines
    5.1.1.2 Poultry Vaccines
    5.1.1.3 Porcine Vaccines
    5.1.1.4 Other Livestock Vaccines
    5.1.2 Companion Animal Vaccines
    5.1.2.1 Canine Vaccines
    5.1.2.2 Feline Vaccines
    5.1.2.3 Equine Vaccines
    5.2 By Technology
    5.2.1 Live Attenuated Vaccines
    5.2.2 Inactivated Vaccines
    5.2.3 Toxoid Vaccines
    5.2.4 Recombinant Vaccines
    5.2.5 Other Technologies
    5.3 Geography
    5.3.1 Europe
    5.3.1.1 Germany
    5.3.1.2 UK
    5.3.1.3 France
    5.3.1.4 Italy
    5.3.1.5 Spain
    5.3.1.6 Rest of Europe

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Merck & Co. Inc.
    6.1.2 Virbac SA
    6.1.3 Hester Biosciences Ltd
    6.1.4 Eli Lilly & Company
    6.1.5 Ceva Sante Animale
    6.1.6 Phibro Animal Health Corp.
    6.1.7 HIPRA
    6.1.8 Zoetis Inc.
    6.1.9 Boehringer Ingelheim International GmbH

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Polymixin Market 2019: Global Size, Industry Share, Outlook, Trends Evaluation, Geographical Segmentation, Business Challenges and Opportunity Analysis till 2024

    Formaldehyde Market 2019 Industry Recent Developments, Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2026

    Baby Needs Market 2019 Global Industry Size, Demand, Growth Analysis, Share, Revenue and Forecast 2023

    Food Freezer Market 2019 Industry Status by Trend Analysis, Growth Status, Revenue Expectation to 2025 | Research Report by Industry Research.co